Literature DB >> 25962589

Quantifying [¹⁸F]fluorodeoxyglucose uptake in the arterial wall: the effects of dual time-point imaging and partial volume effect correction.

Björn A Blomberg1, Arjun Bashyam, Abhinay Ramachandran, Saeid Gholami, Sina Houshmand, Ali Salavati, Tom Werner, Habib Zaidi, Abass Alavi.   

Abstract

PURPOSE: The human arterial wall is smaller than the spatial resolution of current positron emission tomographs. Therefore, partial volume effects should be considered when quantifying arterial wall (18)F-FDG uptake. We evaluated the impact of a novel method for partial volume effect (PVE) correction with contrast-enhanced CT (CECT) assistance on quantification of arterial wall (18)F-FDG uptake at different imaging time-points.
METHODS: Ten subjects were assessed by CECT imaging and dual time-point PET/CT imaging at approximately 60 and 180 min after (18)F-FDG administration. For both time-points, uptake of (18)F-FDG was determined in the aortic wall by calculating the blood pool-corrected maximum standardized uptake value (cSUVMAX) and cSUVMEAN. The PVE-corrected SUVMEAN (pvcSUVMEAN) was also calculated using (18)F-FDG PET/CT and CECT images. Finally, corresponding target-to-background ratios (TBR) were calculated.
RESULTS: At 60 min, pvcSUVMEAN was on average 3.1 times greater than cSUVMAX (P < .0001) and 8.5 times greater than cSUVMEAN (P < .0001). At 180 min, pvcSUVMEAN was on average 2.6 times greater than cSUVMAX (P < .0001) and 6.6 times greater than cSUVMEAN (P < .0001).
CONCLUSION: This study demonstrated that CECT-assisted PVE correction significantly influences quantification of arterial wall (18)F-FDG uptake. Therefore, partial volume effects should be considered when quantifying arterial wall (18)F-FDG uptake with PET.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25962589     DOI: 10.1007/s00259-015-3074-x

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  23 in total

1.  Quantitative assessment of glucose metabolism in the vessel wall of abdominal aortic aneurysms: correlation with histology and role of partial volume correction.

Authors:  Christian Reeps; Ralph A Bundschuh; Jaroslav Pellisek; Michael Herz; Sandra van Marwick; Markus Schwaiger; Hans-Henning Eckstein; Stephan G Nekolla; Markus Essler
Journal:  Int J Cardiovasc Imaging       Date:  2012-07-07       Impact factor: 2.357

2.  MRI-based determination of reference values of thoracic aortic wall thickness in a general population.

Authors:  Birger Mensel; Alexander Quadrat; Tobias Schneider; Jens-Peter Kühn; Marcus Dörr; Henry Völzke; Wolfgang Lieb; Katrin Hegenscheid; Roberto Lorbeer
Journal:  Eur Radiol       Date:  2014-05-11       Impact factor: 5.315

3.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

4.  Hypoxia but not inflammation augments glucose uptake in human macrophages: Implications for imaging atherosclerosis with 18fluorine-labeled 2-deoxy-D-glucose positron emission tomography.

Authors:  Eduardo J Folco; Yuri Sheikine; Viviane Z Rocha; Thomas Christen; Eugenia Shvartz; Galina K Sukhova; Marcelo F Di Carli; Peter Libby
Journal:  J Am Coll Cardiol       Date:  2011-08-02       Impact factor: 24.094

5.  Comparison of methods for magnetic resonance-guided [18-F]fluorodeoxyglucose positron emission tomography in human carotid arteries: reproducibility, partial volume correction, and correlation between methods.

Authors:  David Izquierdo-Garcia; John R Davies; Martin J Graves; James H F Rudd; Jonathan H Gillard; Peter L Weissberg; Tim D Fryer; Elizabeth A Warburton
Journal:  Stroke       Date:  2008-10-16       Impact factor: 7.914

6.  Application of partial volume effect correction and 4D PET in the quantification of FDG avid lung lesions.

Authors:  Ali Salavati; Samuel Borofsky; Teo K Boon-Keng; Sina Houshmand; Benjapa Khiewvan; Babak Saboury; Ion Codreanu; Drew A Torigian; Habib Zaidi; Abass Alavi
Journal:  Mol Imaging Biol       Date:  2015-02       Impact factor: 3.488

7.  18F-FDG PET/CT identifies patients at risk for future vascular events in an otherwise asymptomatic cohort with neoplastic disease.

Authors:  Axel Rominger; Tobias Saam; Sarah Wolpers; Clemens C Cyran; Michael Schmidt; Stefan Foerster; Konstantin Nikolaou; Maximilian F Reiser; Peter Bartenstein; Marcus Hacker
Journal:  J Nucl Med       Date:  2009-09-16       Impact factor: 10.057

8.  A pilot study of changes in (18)F-FDG uptake, calcification and global metabolic activity of the aorta with aging.

Authors:  Gonca G Bural; Drew A Torigian; Elias Botvinick; Mohamed Houseni; Sandip Basu; Wengen Chen; Abass Alavi
Journal:  Hell J Nucl Med       Date:  2009 May-Aug       Impact factor: 1.102

Review 9.  Novel quantitative techniques for assessing regional and global function and structure based on modern imaging modalities: implications for normal variation, aging and diseased states.

Authors:  Sandip Basu; Habib Zaidi; Mohamed Houseni; Gonca Bural; Jay Udupa; Paul Acton; Drew A Torigian; Abass Alavi
Journal:  Semin Nucl Med       Date:  2007-05       Impact factor: 4.446

10.  Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography.

Authors:  J H F Rudd; E A Warburton; T D Fryer; H A Jones; J C Clark; N Antoun; P Johnström; A P Davenport; P J Kirkpatrick; B N Arch; J D Pickard; P L Weissberg
Journal:  Circulation       Date:  2002-06-11       Impact factor: 29.690

View more
  9 in total

1.  18F-FDG PET reveals unique features of large vessel inflammation in patients with Takayasu's arteritis.

Authors:  Elena Incerti; Enrico Tombetti; Federico Fallanca; Elena M Baldissera; Pierpaolo Alongi; Elisabetta Tombolini; Silvia Sartorelli; Maria Grazia Sabbadini; Maurizio Papa; Francesco De Cobelli; Justin C Mason; Luigi Gianolli; Angelo A Manfredi; Maria Picchio
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-02-08       Impact factor: 9.236

2.  Volume-based glucose metabolic analysis of FDG PET/CT: The optimum threshold and conditions to suppress physiological myocardial uptake.

Authors:  Osamu Manabe; Markus Kroenke; Tadao Aikawa; Atsuto Murayama; Masanao Naya; Atsuro Masuda; Noriko Oyama-Manabe; Kenji Hirata; Shiro Watanabe; Tohru Shiga; Chietsugu Katoh; Nagara Tamaki
Journal:  J Nucl Cardiol       Date:  2017-12-14       Impact factor: 5.952

3.  Clinical Factors Associated with Time-Specific Distribution of 18F-Fluorodeoxyglucose in Large-Vessel Vasculitis.

Authors:  Joel S Rosenblum; Kaitlin A Quinn; Casey A Rimland; Nehal N Mehta; Mark A Ahlman; Peter C Grayson
Journal:  Sci Rep       Date:  2019-10-23       Impact factor: 4.379

4.  Observer repeatability and interscan reproducibility of 18F-sodium fluoride coronary microcalcification activity.

Authors:  Evangelos Tzolos; Jacek Kwiecinski; Martin Lyngby Lassen; Sebastien Cadet; Philip D Adamson; Alastair J Moss; Nikhil Joshi; Michelle C Williams; Edwin J R van Beek; Damini Dey; Daniel S Berman; Marc R Dweck; David E Newby; Piotr J Slomka
Journal:  J Nucl Cardiol       Date:  2020-06-11       Impact factor: 5.952

Review 5.  FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC.

Authors:  Riemer H J A Slart
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-04-11       Impact factor: 9.236

6.  Which is the proper reference tissue for measuring the change in FDG PET metabolic volume of cardiac sarcoidosis before and after steroid therapy?

Authors:  Sho Furuya; Osamu Manabe; Hiroshi Ohira; Kenji Hirata; Tadao Aikawa; Masanao Naya; Ichizo Tsujino; Kazuhiro Koyanagawa; Toshihisa Anzai; Noriko Oyama-Manabe; Tohru Shiga
Journal:  EJNMMI Res       Date:  2018-10-05       Impact factor: 3.138

Review 7.  Imaging Atherosclerosis by PET, With Emphasis on the Role of FDG and NaF as Potential Biomarkers for This Disorder.

Authors:  Michael Mayer; Austin J Borja; Emily C Hancin; Thomas Auslander; Mona-Elisabeth Revheim; Mateen C Moghbel; Thomas J Werner; Abass Alavi; Chamith S Rajapakse
Journal:  Front Physiol       Date:  2020-10-22       Impact factor: 4.566

8.  Procedural recommendations of cardiac PET/CT imaging: standardization in inflammatory-, infective-, infiltrative-, and innervation (4Is)-related cardiovascular diseases: a joint collaboration of the EACVI and the EANM.

Authors:  Riemer H J A Slart; Andor W J M Glaudemans; Olivier Gheysens; Mark Lubberink; Tanja Kero; Marc R Dweck; Gilbert Habib; Oliver Gaemperli; Antti Saraste; Alessia Gimelli; Panagiotis Georgoulias; Hein J Verberne; Jan Bucerius; Christoph Rischpler; Fabien Hyafil; Paola A Erba
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-10-27       Impact factor: 9.236

Review 9.  PET-Based Imaging with 18F-FDG and 18F-NaF to Assess Inflammation and Microcalcification in Atherosclerosis and Other Vascular and Thrombotic Disorders.

Authors:  William Y Raynor; Peter Sang Uk Park; Austin J Borja; Yusha Sun; Thomas J Werner; Sze Jia Ng; Hui Chong Lau; Poul Flemming Høilund-Carlsen; Abass Alavi; Mona-Elisabeth Revheim
Journal:  Diagnostics (Basel)       Date:  2021-11-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.